Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Testicular Neoplasms 4Ovarian Neoplasms 4Ovarian Germ Cell Cancer 3Wilms Tumor 2Uterine Cervical Neoplasms 2Teratoma 2Retinoblastoma 2Neuroblastoma 2Medulloblastoma 2Endodermal Sinus Tumor 2Carcinoma, Embryonal 2Astrocytoma 2Uveal Melanoma 1Thrombocytopenia 1Seminoma 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Recurrent Uterine Corpus Sarcoma 1Recurrent Uterine Corpus Carcinoma 1Osteosarcoma 1Optic Nerve Glioma 1Neutropenia 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors 1Neoplasms 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Hepatoblastoma 1

Interventions

Thiotepa 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Busulfan 1Bone Marrow Transplantation 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Granulocyte Colony-Stimulating Factor × Gynecologic × Clear all
NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡